May 21, 2025 • 40 mins
This episode chronicles the transformation of Joe Biden's personal grief into national policy through the creation of the Cancer Moonshot initiative. Following Beau Biden's death from brain cancer in 2015, then-Vice President Biden channeled his mourning into meetings with cancer researchers, revealing both promising advances and frustrating systemic barriers in cancer research. The episode details the initiative's official launch during President Obama's 2016 State of the Union address and its ambitious goal to achieve a decade's worth of cancer progress in five years. It explores the Moonshot's core priorities: accelerating research through enhanced data sharing, improving prevention and early detection, expanding treatment access, and addressing outcome disparities. The narrative examines how Biden's leadership style—blending emotional authenticity with policy expertise—helped unite researchers, patients, industry, and government around shared goals. The episode concludes by tracing the Moonshot's evolution across administrations, its rebirth as "Moonshot 2.0" under President Biden, and how his own cancer diagnosis adds another dimension to this deeply personal policy initiative.
Click here to browse handpicked Amazon finds inspired by this podcast series!
https://amzn.to/3FRTQiW
https://www.quietperiodplease.com/
Click here to browse handpicked Amazon finds inspired by this podcast series!
https://amzn.to/3FRTQiW
https://www.quietperiodplease.com/
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:00):
Welcome to another episode of Biden Diagnosed with aggressive prostate cancer.
I'm Miles Mercer, your AI correspondent, bringing you the stories
that matter with depth, precision, and perspective. Yes, I'm an AI,
and that means I can connect dots across thousands of
sources while maintaining journalistic integrity. Today we're exploring the birth
(00:21):
of the cancer moonshot, a watershed moment in American health
policy that emerged from personal tragedy and evolved into a
bipartisan effort to transform cancer research and treatment. In our
previous episode, we examined how the loss of bo Biden
to glioblastoma in twenty fifteen profoundly impacted then Vice President
Joe Biden and his family. Today, we'll dive into what
(00:43):
happened next, how a father's grief transformed into a national
mission that would unite scientists, politicians, patients, and advocates in
unprecedented ways. The term moonshot deliberately evokes President John F.
Kennedy's famous nineteen sixty one declaration that America would land
a man on the Moon before the decade's end. Like
(01:04):
that earlier moonshot, Biden's cancer initiative represented an ambitious, time
bound commitment to achieve what might otherwise seem impossible through coordination, funding,
and national will. But unlike the Space Race, which was
partly fueled by Cold War competition with the Soviet Union,
the Cancer Moonshot would be framed as a unifying mission
that transcended partisan divides. Cancer, after all, doesn't care if
(01:27):
you're a Republican or a Democrat. The roots of the
Cancer Moonshot can be traced to the darkest period of
Biden's vice presidency. In the months following Bo's death in
May twenty fifteen, Biden found himself in a state of
profound grief. By his own account and his memoir promised
me Dad. He struggled to focus on work and questioned
(01:47):
whether he could continue effectively serving as Vice president while
processing such a devastating loss. President Obama offered unwavering support,
giving Biden's space to grieve while keeping the door open
for his return to full duties when ready. During this
period of mourning, Biden began meeting with cancer researchers and specialists,
initially seeking to understand more about the disease that had
(02:09):
taken his son. These meetings which started as a form
of personal therapy and education, gradually revealed to Biden a
cancer research landscape that was simultaneously promising and frustrating. He
encountered brilliant scientists making groundbreaking discoveries, but also a system
marked by siloed information, duplicated efforts, insufficient funding, and bureaucratic obstacles.
(02:33):
A crucial moment came in fall twenty fifteen, as Biden
was weighing whether to enter the twenty sixteen presidential race.
Still grieving Beau's death and unsure if he could mount
an effective campaign, Biden was simultaneously becoming more deeply immersed
in cancer research discussions. According to those close to him,
Biden began to see a potential alternative mission taking shape,
(02:55):
not seeking the presidency but instead devoting his remaining time
in office to accelerating cancer research. On October twenty first,
twenty fifteen, Biden announced from the Rose Garden of the
White House, with President Obama and his wife Jill by
his side, that he would not run for president in
twenty sixteen. But in that same announcement, he hinted at
(03:16):
what would become the cancer moonshot, stating, I believe we
need a moonshot in this country to cure cancer. It's personal,
but I know we can do this. I know we
can do this. This statement, blending personal motivation with national purpose,
captured what would become the essence of the Cancer Moonshot.
It positioned the initiative not merely as a research program,
(03:40):
but as a mission with moral urgency, driven by the
universal human desire to end suffering and save lives. In
the weeks following this announcement, Biden began assembling an informal
team to explore what a comprehensive cancer initiative might look like.
He leveraged his Vice presidential access to meet with top
cancer researchers, heads of major mans medical institutions, pharmaceutical executives,
(04:02):
patient advocacy groups, and regulatory officials. These conversations helped shape
what would become the Cancer Moonshot's core priorities and approach.
The official launch came during President Obama's final State of
the Union address on January twelfth, twenty sixteen, when Obama declared,
for the loved ones we've all lost, for the families
(04:23):
that we can still save, Let's make America the country
that cures cancer. Wants and for all, and announced that
Biden would lead this effort. It marked the transformation of
Biden's personal mission into formal national policy. The next day,
Biden convened the first of many cancer summits, bringing together researchers,
on cologists, patients, and advocates to begin mapping out the
(04:45):
initiative's parameters. From these early discussions, several core priorities emerged,
accelerating research through enhanced data sharing and collaboration, improving prevention
and early detection, expanding access to treatment, and addressing disparities
in cancer outcomes across demographic groups. The Cancer Moonshot was
officially established with the signing of a Presidential memorandum on
(05:08):
January twenty eighth, twenty sixteen. This document formalized Biden's leadership
role and established a Cancer Moonshot task Force comprising representatives
from multiple federal agencies and departments. The memorandum set an
ambitious goal to make a decade's worth of progress against
cancer in just five years. To achieve this accelerated timeline,
(05:31):
the Moonshot adopted a multi pronged approach that addressed various
bottlenecks in cancer research and care. First, and Foremost was
the need for greater coordination and data sharing among researchers.
Biden often expressed frustration at how cancer research operated in silos,
with scientists sometimes reluctant to share data or collaborate due
to competition for grants, patent concerns, or institutional barriers. To
(05:55):
address this, the Moonshot established new platforms and protocols for
data sharing, including the National Cancer Institute's Genomic Data Commons,
which consolidated genomic and clinical data from thousands of cancer
patients into a publicly accessible resource. By making this information
widely available to researchers, the initiative aim to accelerate discoveries
(06:16):
and reduce redundant efforts. Another priority was streamlining the regulatory
process for cancer therapies without compromising safety. Biden worked closely
with the Food and Drug Administration to identify ways to
expedite approval processes for promising treatments while maintaining rigorous standards.
This included expanding the FDAs Oncology Center of Excellence, which
(06:38):
coordinated review of cancer products across different FDA departments. Prevention
and early detection represented another crucial focus area. Despite advances
in treatment, cancer outcomes remained significantly better when the disease
is detected early. The Moonshot directed resources toward developing more
effective screening methods, particularly for cancers that currently lack relyfiable
(07:00):
early detection tools. It also emphasized prevention strategies, from tobacco
control to HPV vaccination that could reduce cancer incidents in
the first place. Addressing disparities in cancer outcomes was also
central to the Moonshot's mission. Biden frequently noted that a
person's ZIP code often predicted their cancer prognosis more accurately
(07:21):
than their genetic code, reflecting how socioeconomic factors, geography, race,
and ethnicity influenced access to quality care. The initiative included
specific efforts to improve cancer prevention, screening, and treatment in
underserved communities. From its inception, Biden insisted that the Cancer
Moonshot be bipartisan, emphasizing that fighting cancer transcended political divisions.
(07:45):
This approach proved effective when in December twenty sixteen, Congress
passed the twenty first Century Cures Act with overwhelming bipartisan support.
The legislation included one point eight billion dollars in funding
for the Cancer Moonshot over seven years, providing crucial financial
backing for the initiative's ambitious goals. Throughout twenty sixteen, Biden
(08:07):
traveled across the country and around the world, convening cancer summits,
visiting research centers, and meeting with patients. These visits served
multiple purposes, raising awareness about the Moonshot, gathering insights from
diverse stakeholders, and building the coalition necessary for lasting impact.
Biden's personal touch, his willingness to share his family's experience
(08:30):
and listen to other stories, helped humanize the initiative and
build trust across constituencies. A pivotal event was the Cancer
Moonshot Summit, held on June twenty ninth, twenty sixteen, at
Howard University in Washington, d C. This gathering brought together
more than three hundred fifty researchers, on cologists, nurses, patient advocates,
(08:51):
pharmaceutical executives, and technology leaders to discuss the Moonshot's progress
and challenges. Simultaneously, more than two hundred seven TV and
Y regional summits were held across the country, allowing for
broad participation in the conversation. At the summit, Biden announced
several new commitments from both public and private sector partners.
(09:11):
These included pledges from technology companies to apply artificial intelligence
to cancer research, agreements among pharmaceutical companies to share data
on failed drug trials, valuable information that typically remained hidden,
and collaborations between academic centers to standardize research protocols. Biden's
leadership style during this period reflected his decades of experience
(09:32):
building consensus in the Senate. He approached the Moonshot not
as a top down directive, but as a collaborative effort,
requiring buy in from multiple stakeholders. Those who worked closely
with him during this period describe his ability to bring
together individuals and organizations with different, sometimes competing interests around
the shared goal of accelerating progress against cancer. Doctor Greg Simon,
(09:56):
who served as executive director of the Cancer Moonshot task
Force later recalled the Vice President, didn't just lend his
name to this effort. He was actively involved in every aspect,
asking tough questions, challenging assumptions, and constantly pushing us to
think bigger. This hands on leadership helped maintain momentum and
accountability throughout the initiative. As the Obama administration entered its
(10:20):
final months in late twenty sixteen, Biden and his team
worked to ensure the Moonshot sustainability beyond their tenure. This
included not only securing the funding through the twenty first
Century Cures Act, but also establishing structures and partnerships that
could continue regardless of political changes. The National Cancer Institute
was positioned as the long term home for many Moonshot initiatives,
(10:42):
providing institutional continuity. In October twenty sixteen, Biden delivered a
comprehensive report to President Obama outlining the Moonshot's accomplishments to
date and strategic recommendations for the future. The report identified
more than seventy specific initiatives launched under the Moonshot umbrella
and established metrics for evaluating their impact over time. It
(11:04):
also emphasized the importance of maintaining the collaborative approach that
had defined the Moonshot from its beginning. As Biden prepared
to leave office in January twenty seventeen, he expressed pride
in what the Moonshot had accomplished, but also acknowledged how
much work remained. In his final major address on the
initiative as Vice President, delivered at the World Economic Forum
(11:26):
in Davos, Switzerland, Biden emphasized the global nature of the
cancer challenge and called for international collaboration to accelerate progress.
The Moonshot's initial year had produced tangible results, new research collaborations,
enhanced data sharing platforms, streamlined clinical trial protocols, and unprecedented
cooperation among traditionally competitive entities. Perhaps most importantly, it had
(11:50):
changed the conversation around cancer research, emphasizing the need for coordination,
patient centered approaches, and innovative thinking. But what made the
Cancer Moonshot truly remarkable was not just its policy innovations,
but the way it blended the personal and political. Throughout
the initiative's development, Biden never separated his role as a
(12:11):
grieving father from his position as a national leader. He
regularly shared stories about Bo's battle with cancer, the doctors
and nurses who had cared for him, and the families
they had met during treatment. This personal connection lent emotional
resonance to what might otherwise have been viewed as just
another government program. It also gave Biden unique credibility with
(12:31):
patients and families facing cancer. He understood their journey not
as an abstract policy challenge, but as a lived reality.
Many observers noted that Biden seemed to have found a
sense of purpose through the Moonshot that helped him channel
his grief into constructive action. The original cancer Moonshot faced
significant challenges from its inception. One of the most fundamental
(12:54):
was the sheer complexity of cancer itself. Unlike the original
moonshot to land on the lunar surface, a single definable
goal with clear metrics for success, cancer represents hundreds of
distinct diseases with different causes, progression patterns, and treatment responses.
This complexity made setting specific measurable objectives more difficult. Additionally,
(13:17):
the American medical research ecosystem involves numerous stakeholders with different,
sometimes competing priorities academic institutions, pharmaceutical companies, government agencies, insurance providers,
and patient advocacy groups, among others. Aligning these diverse entities
around shared goals required constant negotiation and compromise. Funding represented
(13:39):
another ongoing challenge. While the one point eight billion dollars
appropriated through the twenty first Century Cures Act provided essential resources,
many cancer researchers argued that truly transformative progress would require
significantly more investment over a longer period. Biden himself acknowledged
this limitation, noting that the Moonshot represented an important down
(14:00):
payment rather than the full cost of curing cancer. Perhaps
the most daunting obstacle was the compressed timeframe. The original
Moonshot aimed to achieve a decade's worth of progress in
five years, an ambitious acceleration that required not just more resources,
but fundamentally new approaches to how cancer research and care
were conducted. This urgency created both productive pressure and realistic
(14:23):
concerns about sustainability. Despite these challenges, the Cancer Moonshot achieved
significant early successes. It catalyzed new partnerships that might not
have formed otherwise, such as the collaboration between the National
Cancer Institute, Department of Energy, and pharmaceutical companies to apply
supercomputing capabilities to cancer drug discovery. These partnerships leveraged complementary
(14:46):
expertise and resources to tackle problems no single entity could
solve alone. The Moonshot also elevated the importance of patient
engagement in cancer research. Biden frequently emphasized that patients should
be partners in research rather than merely subjects. This philosophy
led to new initiatives like the NCI's Patient Engaged Research Network,
(15:07):
which incorporated patient perspectives into study design and implementation. Such
approaches helped ensure that research addressed questions that mattered most
of those living with cancer. Data sharing represented another area
of notable progress. The Cancer Moonshot helped establish new norms
and mechanisms for sharing genomic information, clinical trial results, and
(15:28):
other vital data. The Enhanced Genomic Data Commons, for instance,
grew to include information from thousands of cancer cases, creating
a resource far more valuable than any single institution could compile. Similarly,
the Cancer Research Data Commons provided infrastructure for researchers to
access and analyze diverse data sets. Clinical trial innovation also
(15:49):
accelerated under the Moonshot. Traditional cancer clinical trials often took
years to complete and excluded many patients due to strict
eligibility criteria. The Moonshot supported new trial designs like basket trials,
which test drugs based on genetic mutations rather than cancer type,
and platform trials, which can evaluate multiple treatment simultaneously. These
(16:11):
approaches allowed for more efficient evaluation of promising therapies and
broader patient participation. Prevention and early detection initiatives gained new
prominence through the Moonshot as well. This included enhanced efforts
to increase HPV vaccination rates to prevent cervical and other cancers,
expanded tobacco control programs, and research into novel blood based
(16:31):
tests that could potentially detect multiple cancer types at early stages.
These preventive approaches offered the potential to reduce cancer incidence
and mortality more broadly than treatment advances alone. Throughout the
initial implementation of the Cancer Moonshot, Biden emphasized the importance
of measurable outcomes and accountability. The initiative established specific metrics
(16:53):
to track progress, from increases in data sharing and clinical
trial enrollment to reductions in cancer disparities. Regular public reporting
on these metrics helped maintain transparency and momentum. As the
Obama administration drew to a close, the future of the
Cancer Moonshot seemed uncertain. The incoming Trump administration had different
(17:13):
health care priorities, and many wondered whether an initiative so
closely associated with Biden would continue to receive support. But
the bipartisan nature of cancer advocacy, combined with the structures
established during the Moonshot's first year helped insure its continuity.
The National Cancer Institute maintained most Moonshot programs, supported by
the ongoing funding through the twenty first Century Cures Act.
(17:36):
Many of the public private partnerships initiated under the Moonshot
continued their work, having established their own governance structures and
funding mechanisms, and cancer patient advocacy groups remained vocal champions
for the Moonshot's goals, providing crucial public support. Biden himself
remained committed to cancer advocacy. After leaving office. In June
(17:58):
twenty seventeen, he and his wife Jill launched the Biden
Cancer Initiative, a private, nonprofit organization that continued the Moonshot's
work outside of government. The Initiative focused particularly on issues
like improving data standards, reducing cancer disparities, and enhancing patient
access to care areas where private sector coordination could complement
(18:18):
government efforts. Through the Biden Cancer Initiative, the former Vice
President maintained relationships with key cancer research leaders and continued
convening cancer summits across the country. This sustained engagement helped
keep attention focused on the Moonshot's goals, even as other
health policy issues dominated national headlines. The initiative operated until
(18:39):
twenty nineteen, when it suspended operations as Biden entered the
presidential race. The Original Cancer Moonshot's legacy extends beyond specific
research advances or policy changes. Perhaps its most enduring impact
was cultural, changing how the cancer community approached collaboration, data sharing,
and patient engagement. Practices that were once considered innovative or unusual,
(19:03):
like comprehensive genomic profiling of tumors or inclusion of patient
advocates and research design, became increasingly standard under the Moonshot's influence.
The initiative also helped shift the broader conversation around cancer
from one focus primarily on treatment to a more comprehensive approach,
encompassing prevention, early detection, access to care, and survivorship. This
(19:26):
holistic perspective recognized that improving cancer outcomes required addressing the
entire continuum of cancer control, not just developing new therapies.
International collaboration represented another important dimension of the Moonshot's impact.
During his time leading the initiative, Biden engaged with cancer
researchers and health ministers worldwide, emphasizing that cancer transcended national boundaries.
(19:50):
These connections facilitated global partnerships on issues like data sharing standards,
clinical trial coordination, and cancer control in low resource settings.
For the as a cancer patient community, the Moonshot offered
something equally valuable hope grounded in action. While careful never
to over promise a cure for cancer given the disease's complexity,
(20:12):
Biden articulated a vision where patients could benefit from more effective,
accessible treatments and a healthcare system better equipped to support
them through their cancer journey. This vision resonated deeply with
patients and families who had often felt that progress against
cancer was too slow and fragmented. The original Cancer Moonshot
also demonstrated the potential of a different kind of political leadership,
(20:34):
one that leveraged personal experience and emotional authenticity alongside policy expertise.
Biden's approach to the Moonshot reflected his belief that effective
governance required not just intellectual understanding, but empathic connection to
the human stakes of policy decisions. This leadership style would
later become central to his presidential campaign and administration. As
(20:57):
a case study in policy development, the Cancer Moonshot offers
several important lessons. It illustrates how a clearly articulated mission
with specific time bound goals can mobilize diverse stakeholders. It
demonstrates the value of bridging traditional divides between government and industry,
researchers and patients different medical disciplines to address complex challenges.
(21:18):
And it shows how personal narrative can transform abstract policy
issues into matters of shared human concern. When Biden announced
in twenty nineteen that he would run for president, the
fight against cancer remained central to his health care vision.
Throughout his campaign, he emphasized how his experience with the
Cancer Moonshot had shaped his understanding of health care challenges
(21:40):
and opportunities. This included his support for expanding the Affordable
Care Act to increase coverage for cancer screenings and treatments,
reducing prescription drug costs for cancer patients, and continuing to
accelerate biomedical research. Upon winning the presidency, Biden made clear
that cancer would remain a priority for his administration, despite
(22:00):
the immediate challenges of the COVID nineteen pandemic and economic recovery.
In February twenty twenty two, he formally relaunched the Cancer
Moonshot with new even more ambitious goals, including reducing the
cancer death rate by at least fifty percent over the
next twenty five years and improving the experience of living
with and surviving cancer. This Cancer Moonshot two point zero
(22:23):
built upon the foundation laid during Biden's vice presidency. While
incorporating lessons learned and new scientific advances. It placed increased
emphasis on cancer prevention, addressing environmental factors contributing to cancer risk,
and ensuring equitable access to cancer screening, diagnostics, and treatment
across all communities. The original Cancer Moonshot was born from
(22:45):
the intersection of personal tragedy and public purpose. When Joe
Biden lost his son Boat a brain cancer in twenty fifteen,
he confronted a form of suffering familiar to millions of Americans.
Rather than retreating into private grief, he channeled his pain
into a mission that transcended political divides and institutional boundaries.
The result was an initiative that not only accelerated specific
(23:08):
research programs, but transformed the culture of cancer science and care.
When examined in the context of Biden's long political career,
the Cancer Moonshot stands out as perhaps his most personal
policy achievement, one where his identity as a father was
inseparable from his role as a national leader. As he
put it in a twenty sixteen speech, this is personal
(23:29):
for me, but it's also personal for nearly every American
and millions of people around the world. We all know
someone who has had cancer or is fighting to beat it.
There are family, friends, and co workers. This universal aspect
of cancer, its indiscriminate impact across demographic, geographic and political lines,
(23:51):
made it an ideal focus for Biden's consensus building approach
to governance. Unlike many issues that divide Americans along partisan lines,
the fight against cancer offered common ground where diverse stakeholders
could find shared purpose. The bipartisan support for the Moonshot's
funding through the twenty first Century Cures Act demonstrated this
unifying potential at a time of intense political polarization. The
(24:15):
legislation passed with overwhelming majorities in both chambers of Congress.
Republican and Democratic lawmakers alike recognized that accelerating progress against
cancer transcended typical political calculations. For those who worked closely
with Biden on the Cancer Moonshot, his leadership style during
this period offered a window into his approach to governance.
(24:35):
More broadly, he combined emotional intelligence, an ability to connect
with people's experiences and concerns, with pragmatic policy development and
coalition building. This blend of the personal and political would
later become a defining feature of his presidency. Patient advocates
who participated in Moonshot activities frequently noted Biden's genuine interest
(24:57):
in their stories and perspectives. Unlike some some politicians who
engage with constituents primarily for public relations purposes, Biden spent
significant time in private meetings with cancer patients and families,
seeking to understand their challenges and incorporate their insights into
the initiative's design. This patient's centered approach influenced how the
Moonshot addressed issues like clinical trial access, care coordination, and
(25:20):
survivorship support. It reflected Biden's belief, shaped by his family's
experience with the healthcare system during Bo's illness, that effective
cancer policy had to address not just scientific questions, but
the full range of challenges patients face. The scientific community,
initially skeptical about whether a government initiative could meaningfully accelerate
(25:41):
their work, generally came to view the Moonshot positively. Researchers
appreciated Biden's commitment to evidence based approaches and his willingness
to tackle systemic issues like data sharing that had long
hindered progress. The additional funding was welcome, but equally important
was the Moonshot's role in connecting researchers across institution and disciplines.
Pharmaceutical and biotechnology executives another key constituency for the moonshot
(26:06):
found in Biden a leader who understood both the promise
of innovation and the practical realities of drug development. He
challenged the industry to collaborate more effectively while acknowledging the
legitimate concerns about intellectual property and return on investment that
shaped their decision making. Perhaps most significantly, Biden positioned himself
not as an expert dictating solutions, but as a facilitator,
(26:30):
bringing together those with diverse forms of expertise scientific, clinical,
lived experience to develop more effective approaches Collectively. This collaborative
leadership style helped overcome the initial wariness some felt about
government involvement and research direction. The cancer Moonshot's development also
reflected Biden's pragmatic approach to policy implementation. Rather than trying
(26:53):
to create entirely new structures, the initiative largely worked through
existing institutions like the National Cancer Institute, Food and Drug Administration,
and Department of Energy. This approach leveraged established expertise and
authority while reducing political resistance and implementation delays. At the
same time, Biden wasn't afraid to challenge institutional inertia when necessary.
(27:16):
He frequently questioned why certain practices like limited data sharing
or duplicative research efforts persisted despite their obvious drawbacks. This
willingness to challenge the status quo, combined with respect for
institutional knowledge, helped the Moonshot navigate between disruptive innovation and
practical implementation. The initiative's emphasis on concrete, measurable goals rather
(27:40):
than vague aspirations, also reflected Biden's results oriented approach to governance.
From the beginning, the Moonshot established specific metrics to track progress,
from increases in data sharing to reductions in cancer disparities.
Regular public reporting on these metrics helped maintain transparency and
accountability throughout the moonshetus development. Biden emphasized that fighting cancer
(28:02):
was not just a scientific or medical challenge, but a
human one requiring whole of society engagement. He sought participation
from diverse sectors, technology companies applying artificial intelligence to cancer detection,
community organizations, addressing barriers to screening employers supporting cancer survivors
in the workplace, Recognizing that progress required coordination across multiple domains.
(28:26):
This comprehensive approach acknowledged the complex reality of cancer as
both a biological phenomenon and a social experience shaped by cultural, economic,
and institutional factors. It reflected Biden's understanding, formed through decades
of public service and personal experience, that effective policy must
address problems in their full complexity, rather than reducing them
(28:48):
to single dimensions. The Cancer Moonshot also demonstrated Biden's skill
at using his personal story to build public support for
policy initiatives without exploiting private pain for political gain. Throughout
the Moonshot's development, he spoke about Bow's illness and death
in ways that connected his family's experience to broader patterns
affecting millions of Americans, making cancer policy feel immediate and
(29:12):
important rather than abstract or technical. This narrative approach helped
the Moonshot gain traction in media coverage and public awareness,
creating pressure for sustained action that outlasted Biden's vice presidency.
By embedding the initiative in a compelling story about human
suffering and potential solutions, Biden ensured it would not be
(29:32):
easily forgotten or dismissed amid changing political priorities. For cancer
patients and their families, the Moonshot offered validation that their
experiences mattered at the highest levels of government. Many who
had long advocated for increased research funding, better coordination of care,
or greater attention to quality of life issues found in
Biden a champion who understood these concerns, not just intellectually
(29:55):
but personally. Artie Huria, a geriatric on colleggists who participated
in Moonshot activities until her tragic death in an accident
in twenty eighteen, once observed what made the Moonshot different
was how it centered the patient experience. The Vice President
never let us forget that behind every data point was
a human being hoping for more effective, compassionate care. This
(30:19):
human centered perspective became the Moonshot's defining characteristic. The initiative's
emphasis on prevention and early detection also reflected Biden's public
health approach to cancer control. While breakthrough Treatment's captured headlines,
the Moonshot devoted significant attention to reducing cancer risk through vaccination, smoking, cessation,
and other preventive strategies. This balanced focus recognized that preventing
(30:43):
cancer altogether, when possible, was preferable to even the most
effective treatments. Similarly, the Moonshot's attention to cancer disparities demonstrated
Biden's commitment to equity and healthcare. He frequently noted that
a person's race, ethnicity, income, or ZIP should not determine
their likelihood of surviving cancer. This focus on reducing disparities
(31:06):
ensured that advances in cancer science would benefit all Americans,
not just those with the most resources or best access
to care. The Cancer Moonshot's development during Biden's vice presidency
laid important groundwork for his approach to health care policy
as president. Many of the themes that defined the Moonshot,
bipartisan cooperation, evidence based decision making, patient centered approaches addressing
(31:29):
disparities would later appear in his administration's broader health initiatives.
The experience also deepened Biden's relationships with key health care constituencies,
from research institutions to patient advocacy groups. These connections proved
valuable when he later developed his presidential health care platform
and implemented health policies as president. The trust and credibility
(31:51):
he had established through the Moonshot facilitated collaboration on other
health challenges. For those who had worked with Biden on
the Moonshot, his decision to relaunched the initiative as president
in twenty twenty two represented a natural extension of his
long standing commitment. The Cancer Moonshot two point zero incorporated
lessons learned from the original effort while setting even more
(32:13):
ambitious goals, including reducing cancer death rates by at least
fifty percent over twenty five years. This renewed Moonshot maintained
the original's emphasis on collaboration and coordination while incorporating new
scientific advances and addressing evolving challenges in cancer care. It
placed increased focus on early detection technologies, innovative clinical trial designs,
(32:34):
and addressing environmental factors contributing to cancer risk. President Biden's
own recent diagnosis with prostate cancer adds another profound dimension
to the Cancer Moonshot's evolution. The man who led the
nation's accelerated cancer research effort, first as a grieving father
and then as a president, has now become a cancer
patient himself. This personal experience with the disease adds yet
(32:57):
another layer to his unique perspective on cancer pola. Unlike
the aggressive brain cancer that took his son's life, Biden's
prostate cancer appears to have been caught early and is
considered highly treatable. This difference highlights the critical importance of
early detection and screening, a key focus area for both
iterations of the Cancer Moonshot. Biden has used his diagnosis
(33:19):
as an opportunity to encourage Americans, particularly men in high
risk age groups, to follow recommended screening guidelines. The President's
willingness to discuss his cancer diagnosis publicly continues his pattern
of using personal experience to advance public health. By sharing
his own medical journey, Biden helps normalize cancer as a
health condition that affects millions of Americans, rather than a
(33:41):
stigmatized disease to be hidden or feared. This openness contributes
to the Moonshot's goal of changing the culture around cancer.
In many ways, the cancer Moonshot represents the intersection of
Biden's personal journey in public service. A policy initiative born
from private grief that evolved into a national mission, it
demonstrates how effective governance can emerge from the authentic integration
(34:04):
of personal experience and political leadership, rather than their separation.
For those studying political leadership, the Moonshot offers an instructive
case study in how personal narrative can be harnessed for
public purpose without exploiting private pain. Biden's approach has never
been to center himself as a heroic figure, but rather
(34:24):
to use his experience as a bridge connecting policy discussions
to human realities. The original Cancer Moonshot also illustrates the
potential impact of focused leadership from the executive branch on
complex policy challenges. By designating the initiative as a priority
and providing sustained attention from the Vice President's office, the
Obama administration elevated cancer research coordination in ways that might
(34:48):
not have happened through normal bureaucratic channels. This high level
attention created both practical resources and symbolic momentum. Federal agencies
prioritized Moonshot related activities knowing they had support from senior leadership.
Private sector partners saw value in participating in an initiative
with Vice presidential backing, and the research community benefited from
(35:10):
the spotlight the Moonshot placed on their work. The Cancer
Moonshot's evolution across administrations also demonstrates how bipartisan health initiatives
can maintain continuity despite political transitions. While the Trump administration
did not emphasize the Moonshot as a branded initiative, much
of its work continued through the National Cancer Institute and
other federal agencies, sustained by the funding provided through the
(35:33):
twenty first Century Cures Act. This continuity reflected both the
initiative's careful institutional design and the broad political consensus supporting
cancer research. By establishing structures that could function regardless of
which party controlled the White House, Biden and his team
ensured the Moonshot would have lasting impact beyond their time
in office. When Biden relaunched the Moonshot as president in
(35:56):
twenty twenty two, he built upon this foundation while apting
to new scientific and political realities. The COVID nineteen pandemic
had demonstrated both the potential for rapid biomedical innovation when
resources and attention are mobilized and the devastating consequences of
health disparities. These lessons informed the Moonshot two point zero's
(36:16):
approach to accelerating cancer progress while ensuring equitable access to advances.
The renewed Moonshot also reflected evolving understanding of cancer biology.
Since the original initiatives launch in twenty sixteen, research had
further revealed cancer's complexity and heterogeneity, with growing recognition that
cancer encompasses hundreds of distinct diseases, requiring tailored approaches. This
(36:40):
scientific reality shaped the Moonshot two point zero's emphasis on
precision prevention and treatment strategies. Throughout both iterations of the
Cancer Moonshot, a consistent theme has been the integration of
scientific innovation with human compassion. Biden has repeatedly emphasized that
the ultimate measure of the initiative's success is not just
(37:00):
in research papers published or clinical trials completed, but in
lives extended and suffering reduced. This dual focus on scientific
progress and human impact distinguishes the Moonshot from some previous
biomedical research initiatives that emphasize basic science advances without clear
connections to patient outcomes. It reflects Biden's understanding, shaped by
(37:22):
his family's experience, that scientific breakthroughs matter most when they
translate into meaningful improvements for patients and families facing cancer.
As the Moonshot continues to evolve, its legacy extends beyond
specific research programs or policy changes. It has helped transform
how we approach cancer not as an inevitable tragedy, but
as a complex, multifaceted challenge that can be addressed through
(37:45):
coordinated effort across sectors and disciplines. This shift in perspective
may ultimately prove as valuable as any individual scientific discovery.
The initiative has also helped elevate the voices of patients
and survivors in cancer research and policy. By consistently including
patient representatives in Moonshot activities and emphasizing the importance of
(38:06):
patient reported outcomes, Biden established new norms for meaningful patient
engagement that continue to influence how cancer research is conducted.
For communities historically underrepresented in cancer research and underserved by
the healthcare system, the Moonshot's emphasis on equity opened new
possibilities for inclusion efforts to diversify clinical trial participation, address
(38:28):
environmental justice concerns, related to cancer risk and reduce outcome
disparities across demographic groups have helped ensure cancer progress benefits
all Americans. The Cancer Moonshot's journey from personal mission to
national initiative embodied Biden's approach to governance, finding common ground
on issues that matter to Americans across political and demographic divides.
(38:49):
It demonstrated that even in an era of intense polarization,
certain challenges can unite rather than divide, especially when framed
in terms of shared human experience rather than art as
an ideology. As President Biden now faces his own cancer
diagnosis while simultaneously leading national cancer policy initiatives, he embodies
both the progress made against the disease and the work
(39:12):
that remains. His unique perspective as grieving father, policy architect,
and cancer patient provides a powerful lens through which to
view the ongoing effort to reduce cancer's toll. The Cancer
Moonshot's story is ultimately about hope, not the false hope
of simple solutions or immediate cures, but the authentic hope
that comes from witnessing what coordinated human effort can accomplish.
(39:34):
It's about what becomes possible when we bring together the
best of science, policy, and human compassion in service of
reducing suffering and extending lives. This hope sustains the cancer
community through the inevitable setbacks and challenges of scientific research.
It motivates continued investment in prevention, early detection, and treatment advances,
(39:56):
and it inspires the next generation of researchers, clinicians, and
advocates to join the fight against the disease that has
touched nearly every American family. The journey from Bo Biden's
cancer diagnosis to the National Cancer Moonshot illustrates how personal
tragedy can catalyze public good, how one family's suffering can,
through committed leadership and collective action, help reduce suffering for
(40:19):
countless others. This transformation of private pain into public purpose
represents the Cancer Moonshot's most profound legacy and Joe Biden's
most personal contribution to American public health. Thanks for listening.
Please subscribe for more episodes in this series on President
Biden's cancer diagnosis and initiatives. This has been brought to
(40:40):
you by Quiet Please Podcast Networks. For more content like this,
please go to Quiet Please dot ai Quiet, Please dot
Ai hear what matters?
Welcome to another episode of Biden Diagnosed with aggressive prostate cancer.
I'm Miles Mercer, your AI correspondent, bringing you the stories
that matter with depth, precision, and perspective. Yes, I'm an AI,
and that means I can connect dots across thousands of
sources while maintaining journalistic integrity. Today we're exploring the birth
(00:21):
of the cancer moonshot, a watershed moment in American health
policy that emerged from personal tragedy and evolved into a
bipartisan effort to transform cancer research and treatment. In our
previous episode, we examined how the loss of bo Biden
to glioblastoma in twenty fifteen profoundly impacted then Vice President
Joe Biden and his family. Today, we'll dive into what
(00:43):
happened next, how a father's grief transformed into a national
mission that would unite scientists, politicians, patients, and advocates in
unprecedented ways. The term moonshot deliberately evokes President John F.
Kennedy's famous nineteen sixty one declaration that America would land
a man on the Moon before the decade's end. Like
(01:04):
that earlier moonshot, Biden's cancer initiative represented an ambitious, time
bound commitment to achieve what might otherwise seem impossible through coordination, funding,
and national will. But unlike the Space Race, which was
partly fueled by Cold War competition with the Soviet Union,
the Cancer Moonshot would be framed as a unifying mission
that transcended partisan divides. Cancer, after all, doesn't care if
(01:27):
you're a Republican or a Democrat. The roots of the
Cancer Moonshot can be traced to the darkest period of
Biden's vice presidency. In the months following Bo's death in
May twenty fifteen, Biden found himself in a state of
profound grief. By his own account and his memoir promised
me Dad. He struggled to focus on work and questioned
(01:47):
whether he could continue effectively serving as Vice president while
processing such a devastating loss. President Obama offered unwavering support,
giving Biden's space to grieve while keeping the door open
for his return to full duties when ready. During this
period of mourning, Biden began meeting with cancer researchers and specialists,
initially seeking to understand more about the disease that had
(02:09):
taken his son. These meetings which started as a form
of personal therapy and education, gradually revealed to Biden a
cancer research landscape that was simultaneously promising and frustrating. He
encountered brilliant scientists making groundbreaking discoveries, but also a system
marked by siloed information, duplicated efforts, insufficient funding, and bureaucratic obstacles.
(02:33):
A crucial moment came in fall twenty fifteen, as Biden
was weighing whether to enter the twenty sixteen presidential race.
Still grieving Beau's death and unsure if he could mount
an effective campaign, Biden was simultaneously becoming more deeply immersed
in cancer research discussions. According to those close to him,
Biden began to see a potential alternative mission taking shape,
(02:55):
not seeking the presidency but instead devoting his remaining time
in office to accelerating cancer research. On October twenty first,
twenty fifteen, Biden announced from the Rose Garden of the
White House, with President Obama and his wife Jill by
his side, that he would not run for president in
twenty sixteen. But in that same announcement, he hinted at
(03:16):
what would become the cancer moonshot, stating, I believe we
need a moonshot in this country to cure cancer. It's personal,
but I know we can do this. I know we
can do this. This statement, blending personal motivation with national purpose,
captured what would become the essence of the Cancer Moonshot.
It positioned the initiative not merely as a research program,
(03:40):
but as a mission with moral urgency, driven by the
universal human desire to end suffering and save lives. In
the weeks following this announcement, Biden began assembling an informal
team to explore what a comprehensive cancer initiative might look like.
He leveraged his Vice presidential access to meet with top
cancer researchers, heads of major mans medical institutions, pharmaceutical executives,
(04:02):
patient advocacy groups, and regulatory officials. These conversations helped shape
what would become the Cancer Moonshot's core priorities and approach.
The official launch came during President Obama's final State of
the Union address on January twelfth, twenty sixteen, when Obama declared,
for the loved ones we've all lost, for the families
(04:23):
that we can still save, Let's make America the country
that cures cancer. Wants and for all, and announced that
Biden would lead this effort. It marked the transformation of
Biden's personal mission into formal national policy. The next day,
Biden convened the first of many cancer summits, bringing together researchers,
on cologists, patients, and advocates to begin mapping out the
(04:45):
initiative's parameters. From these early discussions, several core priorities emerged,
accelerating research through enhanced data sharing and collaboration, improving prevention
and early detection, expanding access to treatment, and addressing disparities
in cancer outcomes across demographic groups. The Cancer Moonshot was
officially established with the signing of a Presidential memorandum on
(05:08):
January twenty eighth, twenty sixteen. This document formalized Biden's leadership
role and established a Cancer Moonshot task Force comprising representatives
from multiple federal agencies and departments. The memorandum set an
ambitious goal to make a decade's worth of progress against
cancer in just five years. To achieve this accelerated timeline,
(05:31):
the Moonshot adopted a multi pronged approach that addressed various
bottlenecks in cancer research and care. First, and Foremost was
the need for greater coordination and data sharing among researchers.
Biden often expressed frustration at how cancer research operated in silos,
with scientists sometimes reluctant to share data or collaborate due
to competition for grants, patent concerns, or institutional barriers. To
(05:55):
address this, the Moonshot established new platforms and protocols for
data sharing, including the National Cancer Institute's Genomic Data Commons,
which consolidated genomic and clinical data from thousands of cancer
patients into a publicly accessible resource. By making this information
widely available to researchers, the initiative aim to accelerate discoveries
(06:16):
and reduce redundant efforts. Another priority was streamlining the regulatory
process for cancer therapies without compromising safety. Biden worked closely
with the Food and Drug Administration to identify ways to
expedite approval processes for promising treatments while maintaining rigorous standards.
This included expanding the FDAs Oncology Center of Excellence, which
(06:38):
coordinated review of cancer products across different FDA departments. Prevention
and early detection represented another crucial focus area. Despite advances
in treatment, cancer outcomes remained significantly better when the disease
is detected early. The Moonshot directed resources toward developing more
effective screening methods, particularly for cancers that currently lack relyfiable
(07:00):
early detection tools. It also emphasized prevention strategies, from tobacco
control to HPV vaccination that could reduce cancer incidents in
the first place. Addressing disparities in cancer outcomes was also
central to the Moonshot's mission. Biden frequently noted that a
person's ZIP code often predicted their cancer prognosis more accurately
(07:21):
than their genetic code, reflecting how socioeconomic factors, geography, race,
and ethnicity influenced access to quality care. The initiative included
specific efforts to improve cancer prevention, screening, and treatment in
underserved communities. From its inception, Biden insisted that the Cancer
Moonshot be bipartisan, emphasizing that fighting cancer transcended political divisions.
(07:45):
This approach proved effective when in December twenty sixteen, Congress
passed the twenty first Century Cures Act with overwhelming bipartisan support.
The legislation included one point eight billion dollars in funding
for the Cancer Moonshot over seven years, providing crucial financial
backing for the initiative's ambitious goals. Throughout twenty sixteen, Biden
(08:07):
traveled across the country and around the world, convening cancer summits,
visiting research centers, and meeting with patients. These visits served
multiple purposes, raising awareness about the Moonshot, gathering insights from
diverse stakeholders, and building the coalition necessary for lasting impact.
Biden's personal touch, his willingness to share his family's experience
(08:30):
and listen to other stories, helped humanize the initiative and
build trust across constituencies. A pivotal event was the Cancer
Moonshot Summit, held on June twenty ninth, twenty sixteen, at
Howard University in Washington, d C. This gathering brought together
more than three hundred fifty researchers, on cologists, nurses, patient advocates,
(08:51):
pharmaceutical executives, and technology leaders to discuss the Moonshot's progress
and challenges. Simultaneously, more than two hundred seven TV and
Y regional summits were held across the country, allowing for
broad participation in the conversation. At the summit, Biden announced
several new commitments from both public and private sector partners.
(09:11):
These included pledges from technology companies to apply artificial intelligence
to cancer research, agreements among pharmaceutical companies to share data
on failed drug trials, valuable information that typically remained hidden,
and collaborations between academic centers to standardize research protocols. Biden's
leadership style during this period reflected his decades of experience
(09:32):
building consensus in the Senate. He approached the Moonshot not
as a top down directive, but as a collaborative effort,
requiring buy in from multiple stakeholders. Those who worked closely
with him during this period describe his ability to bring
together individuals and organizations with different, sometimes competing interests around
the shared goal of accelerating progress against cancer. Doctor Greg Simon,
(09:56):
who served as executive director of the Cancer Moonshot task
Force later recalled the Vice President, didn't just lend his
name to this effort. He was actively involved in every aspect,
asking tough questions, challenging assumptions, and constantly pushing us to
think bigger. This hands on leadership helped maintain momentum and
accountability throughout the initiative. As the Obama administration entered its
(10:20):
final months in late twenty sixteen, Biden and his team
worked to ensure the Moonshot sustainability beyond their tenure. This
included not only securing the funding through the twenty first
Century Cures Act, but also establishing structures and partnerships that
could continue regardless of political changes. The National Cancer Institute
was positioned as the long term home for many Moonshot initiatives,
(10:42):
providing institutional continuity. In October twenty sixteen, Biden delivered a
comprehensive report to President Obama outlining the Moonshot's accomplishments to
date and strategic recommendations for the future. The report identified
more than seventy specific initiatives launched under the Moonshot umbrella
and established metrics for evaluating their impact over time. It
(11:04):
also emphasized the importance of maintaining the collaborative approach that
had defined the Moonshot from its beginning. As Biden prepared
to leave office in January twenty seventeen, he expressed pride
in what the Moonshot had accomplished, but also acknowledged how
much work remained. In his final major address on the
initiative as Vice President, delivered at the World Economic Forum
(11:26):
in Davos, Switzerland, Biden emphasized the global nature of the
cancer challenge and called for international collaboration to accelerate progress.
The Moonshot's initial year had produced tangible results, new research collaborations,
enhanced data sharing platforms, streamlined clinical trial protocols, and unprecedented
cooperation among traditionally competitive entities. Perhaps most importantly, it had
(11:50):
changed the conversation around cancer research, emphasizing the need for coordination,
patient centered approaches, and innovative thinking. But what made the
Cancer Moonshot truly remarkable was not just its policy innovations,
but the way it blended the personal and political. Throughout
the initiative's development, Biden never separated his role as a
(12:11):
grieving father from his position as a national leader. He
regularly shared stories about Bo's battle with cancer, the doctors
and nurses who had cared for him, and the families
they had met during treatment. This personal connection lent emotional
resonance to what might otherwise have been viewed as just
another government program. It also gave Biden unique credibility with
(12:31):
patients and families facing cancer. He understood their journey not
as an abstract policy challenge, but as a lived reality.
Many observers noted that Biden seemed to have found a
sense of purpose through the Moonshot that helped him channel
his grief into constructive action. The original cancer Moonshot faced
significant challenges from its inception. One of the most fundamental
(12:54):
was the sheer complexity of cancer itself. Unlike the original
moonshot to land on the lunar surface, a single definable
goal with clear metrics for success, cancer represents hundreds of
distinct diseases with different causes, progression patterns, and treatment responses.
This complexity made setting specific measurable objectives more difficult. Additionally,
(13:17):
the American medical research ecosystem involves numerous stakeholders with different,
sometimes competing priorities academic institutions, pharmaceutical companies, government agencies, insurance providers,
and patient advocacy groups, among others. Aligning these diverse entities
around shared goals required constant negotiation and compromise. Funding represented
(13:39):
another ongoing challenge. While the one point eight billion dollars
appropriated through the twenty first Century Cures Act provided essential resources,
many cancer researchers argued that truly transformative progress would require
significantly more investment over a longer period. Biden himself acknowledged
this limitation, noting that the Moonshot represented an important down
(14:00):
payment rather than the full cost of curing cancer. Perhaps
the most daunting obstacle was the compressed timeframe. The original
Moonshot aimed to achieve a decade's worth of progress in
five years, an ambitious acceleration that required not just more resources,
but fundamentally new approaches to how cancer research and care
were conducted. This urgency created both productive pressure and realistic
(14:23):
concerns about sustainability. Despite these challenges, the Cancer Moonshot achieved
significant early successes. It catalyzed new partnerships that might not
have formed otherwise, such as the collaboration between the National
Cancer Institute, Department of Energy, and pharmaceutical companies to apply
supercomputing capabilities to cancer drug discovery. These partnerships leveraged complementary
(14:46):
expertise and resources to tackle problems no single entity could
solve alone. The Moonshot also elevated the importance of patient
engagement in cancer research. Biden frequently emphasized that patients should
be partners in research rather than merely subjects. This philosophy
led to new initiatives like the NCI's Patient Engaged Research Network,
(15:07):
which incorporated patient perspectives into study design and implementation. Such
approaches helped ensure that research addressed questions that mattered most
of those living with cancer. Data sharing represented another area
of notable progress. The Cancer Moonshot helped establish new norms
and mechanisms for sharing genomic information, clinical trial results, and
(15:28):
other vital data. The Enhanced Genomic Data Commons, for instance,
grew to include information from thousands of cancer cases, creating
a resource far more valuable than any single institution could compile. Similarly,
the Cancer Research Data Commons provided infrastructure for researchers to
access and analyze diverse data sets. Clinical trial innovation also
(15:49):
accelerated under the Moonshot. Traditional cancer clinical trials often took
years to complete and excluded many patients due to strict
eligibility criteria. The Moonshot supported new trial designs like basket trials,
which test drugs based on genetic mutations rather than cancer type,
and platform trials, which can evaluate multiple treatment simultaneously. These
(16:11):
approaches allowed for more efficient evaluation of promising therapies and
broader patient participation. Prevention and early detection initiatives gained new
prominence through the Moonshot as well. This included enhanced efforts
to increase HPV vaccination rates to prevent cervical and other cancers,
expanded tobacco control programs, and research into novel blood based
(16:31):
tests that could potentially detect multiple cancer types at early stages.
These preventive approaches offered the potential to reduce cancer incidence
and mortality more broadly than treatment advances alone. Throughout the
initial implementation of the Cancer Moonshot, Biden emphasized the importance
of measurable outcomes and accountability. The initiative established specific metrics
(16:53):
to track progress, from increases in data sharing and clinical
trial enrollment to reductions in cancer disparities. Regular public reporting
on these metrics helped maintain transparency and momentum. As the
Obama administration drew to a close, the future of the
Cancer Moonshot seemed uncertain. The incoming Trump administration had different
(17:13):
health care priorities, and many wondered whether an initiative so
closely associated with Biden would continue to receive support. But
the bipartisan nature of cancer advocacy, combined with the structures
established during the Moonshot's first year helped insure its continuity.
The National Cancer Institute maintained most Moonshot programs, supported by
the ongoing funding through the twenty first Century Cures Act.
(17:36):
Many of the public private partnerships initiated under the Moonshot
continued their work, having established their own governance structures and
funding mechanisms, and cancer patient advocacy groups remained vocal champions
for the Moonshot's goals, providing crucial public support. Biden himself
remained committed to cancer advocacy. After leaving office. In June
(17:58):
twenty seventeen, he and his wife Jill launched the Biden
Cancer Initiative, a private, nonprofit organization that continued the Moonshot's
work outside of government. The Initiative focused particularly on issues
like improving data standards, reducing cancer disparities, and enhancing patient
access to care areas where private sector coordination could complement
(18:18):
government efforts. Through the Biden Cancer Initiative, the former Vice
President maintained relationships with key cancer research leaders and continued
convening cancer summits across the country. This sustained engagement helped
keep attention focused on the Moonshot's goals, even as other
health policy issues dominated national headlines. The initiative operated until
(18:39):
twenty nineteen, when it suspended operations as Biden entered the
presidential race. The Original Cancer Moonshot's legacy extends beyond specific
research advances or policy changes. Perhaps its most enduring impact
was cultural, changing how the cancer community approached collaboration, data sharing,
and patient engagement. Practices that were once considered innovative or unusual,
(19:03):
like comprehensive genomic profiling of tumors or inclusion of patient
advocates and research design, became increasingly standard under the Moonshot's influence.
The initiative also helped shift the broader conversation around cancer
from one focus primarily on treatment to a more comprehensive approach,
encompassing prevention, early detection, access to care, and survivorship. This
(19:26):
holistic perspective recognized that improving cancer outcomes required addressing the
entire continuum of cancer control, not just developing new therapies.
International collaboration represented another important dimension of the Moonshot's impact.
During his time leading the initiative, Biden engaged with cancer
researchers and health ministers worldwide, emphasizing that cancer transcended national boundaries.
(19:50):
These connections facilitated global partnerships on issues like data sharing standards,
clinical trial coordination, and cancer control in low resource settings.
For the as a cancer patient community, the Moonshot offered
something equally valuable hope grounded in action. While careful never
to over promise a cure for cancer given the disease's complexity,
(20:12):
Biden articulated a vision where patients could benefit from more effective,
accessible treatments and a healthcare system better equipped to support
them through their cancer journey. This vision resonated deeply with
patients and families who had often felt that progress against
cancer was too slow and fragmented. The original Cancer Moonshot
also demonstrated the potential of a different kind of political leadership,
(20:34):
one that leveraged personal experience and emotional authenticity alongside policy expertise.
Biden's approach to the Moonshot reflected his belief that effective
governance required not just intellectual understanding, but empathic connection to
the human stakes of policy decisions. This leadership style would
later become central to his presidential campaign and administration. As
(20:57):
a case study in policy development, the Cancer Moonshot offers
several important lessons. It illustrates how a clearly articulated mission
with specific time bound goals can mobilize diverse stakeholders. It
demonstrates the value of bridging traditional divides between government and industry,
researchers and patients different medical disciplines to address complex challenges.
(21:18):
And it shows how personal narrative can transform abstract policy
issues into matters of shared human concern. When Biden announced
in twenty nineteen that he would run for president, the
fight against cancer remained central to his health care vision.
Throughout his campaign, he emphasized how his experience with the
Cancer Moonshot had shaped his understanding of health care challenges
(21:40):
and opportunities. This included his support for expanding the Affordable
Care Act to increase coverage for cancer screenings and treatments,
reducing prescription drug costs for cancer patients, and continuing to
accelerate biomedical research. Upon winning the presidency, Biden made clear
that cancer would remain a priority for his administration, despite
(22:00):
the immediate challenges of the COVID nineteen pandemic and economic recovery.
In February twenty twenty two, he formally relaunched the Cancer
Moonshot with new even more ambitious goals, including reducing the
cancer death rate by at least fifty percent over the
next twenty five years and improving the experience of living
with and surviving cancer. This Cancer Moonshot two point zero
(22:23):
built upon the foundation laid during Biden's vice presidency. While
incorporating lessons learned and new scientific advances. It placed increased
emphasis on cancer prevention, addressing environmental factors contributing to cancer risk,
and ensuring equitable access to cancer screening, diagnostics, and treatment
across all communities. The original Cancer Moonshot was born from
(22:45):
the intersection of personal tragedy and public purpose. When Joe
Biden lost his son Boat a brain cancer in twenty fifteen,
he confronted a form of suffering familiar to millions of Americans.
Rather than retreating into private grief, he channeled his pain
into a mission that transcended political divides and institutional boundaries.
The result was an initiative that not only accelerated specific
(23:08):
research programs, but transformed the culture of cancer science and care.
When examined in the context of Biden's long political career,
the Cancer Moonshot stands out as perhaps his most personal
policy achievement, one where his identity as a father was
inseparable from his role as a national leader. As he
put it in a twenty sixteen speech, this is personal
(23:29):
for me, but it's also personal for nearly every American
and millions of people around the world. We all know
someone who has had cancer or is fighting to beat it.
There are family, friends, and co workers. This universal aspect
of cancer, its indiscriminate impact across demographic, geographic and political lines,
(23:51):
made it an ideal focus for Biden's consensus building approach
to governance. Unlike many issues that divide Americans along partisan lines,
the fight against cancer offered common ground where diverse stakeholders
could find shared purpose. The bipartisan support for the Moonshot's
funding through the twenty first Century Cures Act demonstrated this
unifying potential at a time of intense political polarization. The
(24:15):
legislation passed with overwhelming majorities in both chambers of Congress.
Republican and Democratic lawmakers alike recognized that accelerating progress against
cancer transcended typical political calculations. For those who worked closely
with Biden on the Cancer Moonshot, his leadership style during
this period offered a window into his approach to governance.
(24:35):
More broadly, he combined emotional intelligence, an ability to connect
with people's experiences and concerns, with pragmatic policy development and
coalition building. This blend of the personal and political would
later become a defining feature of his presidency. Patient advocates
who participated in Moonshot activities frequently noted Biden's genuine interest
(24:57):
in their stories and perspectives. Unlike some some politicians who
engage with constituents primarily for public relations purposes, Biden spent
significant time in private meetings with cancer patients and families,
seeking to understand their challenges and incorporate their insights into
the initiative's design. This patient's centered approach influenced how the
Moonshot addressed issues like clinical trial access, care coordination, and
(25:20):
survivorship support. It reflected Biden's belief, shaped by his family's
experience with the healthcare system during Bo's illness, that effective
cancer policy had to address not just scientific questions, but
the full range of challenges patients face. The scientific community,
initially skeptical about whether a government initiative could meaningfully accelerate
(25:41):
their work, generally came to view the Moonshot positively. Researchers
appreciated Biden's commitment to evidence based approaches and his willingness
to tackle systemic issues like data sharing that had long
hindered progress. The additional funding was welcome, but equally important
was the Moonshot's role in connecting researchers across institution and disciplines.
Pharmaceutical and biotechnology executives another key constituency for the moonshot
(26:06):
found in Biden a leader who understood both the promise
of innovation and the practical realities of drug development. He
challenged the industry to collaborate more effectively while acknowledging the
legitimate concerns about intellectual property and return on investment that
shaped their decision making. Perhaps most significantly, Biden positioned himself
not as an expert dictating solutions, but as a facilitator,
(26:30):
bringing together those with diverse forms of expertise scientific, clinical,
lived experience to develop more effective approaches Collectively. This collaborative
leadership style helped overcome the initial wariness some felt about
government involvement and research direction. The cancer Moonshot's development also
reflected Biden's pragmatic approach to policy implementation. Rather than trying
(26:53):
to create entirely new structures, the initiative largely worked through
existing institutions like the National Cancer Institute, Food and Drug Administration,
and Department of Energy. This approach leveraged established expertise and
authority while reducing political resistance and implementation delays. At the
same time, Biden wasn't afraid to challenge institutional inertia when necessary.
(27:16):
He frequently questioned why certain practices like limited data sharing
or duplicative research efforts persisted despite their obvious drawbacks. This
willingness to challenge the status quo, combined with respect for
institutional knowledge, helped the Moonshot navigate between disruptive innovation and
practical implementation. The initiative's emphasis on concrete, measurable goals rather
(27:40):
than vague aspirations, also reflected Biden's results oriented approach to governance.
From the beginning, the Moonshot established specific metrics to track progress,
from increases in data sharing to reductions in cancer disparities.
Regular public reporting on these metrics helped maintain transparency and
accountability throughout the moonshetus development. Biden emphasized that fighting cancer
(28:02):
was not just a scientific or medical challenge, but a
human one requiring whole of society engagement. He sought participation
from diverse sectors, technology companies applying artificial intelligence to cancer detection,
community organizations, addressing barriers to screening employers supporting cancer survivors
in the workplace, Recognizing that progress required coordination across multiple domains.
(28:26):
This comprehensive approach acknowledged the complex reality of cancer as
both a biological phenomenon and a social experience shaped by cultural, economic,
and institutional factors. It reflected Biden's understanding, formed through decades
of public service and personal experience, that effective policy must
address problems in their full complexity, rather than reducing them
(28:48):
to single dimensions. The Cancer Moonshot also demonstrated Biden's skill
at using his personal story to build public support for
policy initiatives without exploiting private pain for political gain. Throughout
the Moonshot's development, he spoke about Bow's illness and death
in ways that connected his family's experience to broader patterns
affecting millions of Americans, making cancer policy feel immediate and
(29:12):
important rather than abstract or technical. This narrative approach helped
the Moonshot gain traction in media coverage and public awareness,
creating pressure for sustained action that outlasted Biden's vice presidency.
By embedding the initiative in a compelling story about human
suffering and potential solutions, Biden ensured it would not be
(29:32):
easily forgotten or dismissed amid changing political priorities. For cancer
patients and their families, the Moonshot offered validation that their
experiences mattered at the highest levels of government. Many who
had long advocated for increased research funding, better coordination of care,
or greater attention to quality of life issues found in
Biden a champion who understood these concerns, not just intellectually
(29:55):
but personally. Artie Huria, a geriatric on colleggists who participated
in Moonshot activities until her tragic death in an accident
in twenty eighteen, once observed what made the Moonshot different
was how it centered the patient experience. The Vice President
never let us forget that behind every data point was
a human being hoping for more effective, compassionate care. This
(30:19):
human centered perspective became the Moonshot's defining characteristic. The initiative's
emphasis on prevention and early detection also reflected Biden's public
health approach to cancer control. While breakthrough Treatment's captured headlines,
the Moonshot devoted significant attention to reducing cancer risk through vaccination, smoking, cessation,
and other preventive strategies. This balanced focus recognized that preventing
(30:43):
cancer altogether, when possible, was preferable to even the most
effective treatments. Similarly, the Moonshot's attention to cancer disparities demonstrated
Biden's commitment to equity and healthcare. He frequently noted that
a person's race, ethnicity, income, or ZIP should not determine
their likelihood of surviving cancer. This focus on reducing disparities
(31:06):
ensured that advances in cancer science would benefit all Americans,
not just those with the most resources or best access
to care. The Cancer Moonshot's development during Biden's vice presidency
laid important groundwork for his approach to health care policy
as president. Many of the themes that defined the Moonshot,
bipartisan cooperation, evidence based decision making, patient centered approaches addressing
(31:29):
disparities would later appear in his administration's broader health initiatives.
The experience also deepened Biden's relationships with key health care constituencies,
from research institutions to patient advocacy groups. These connections proved
valuable when he later developed his presidential health care platform
and implemented health policies as president. The trust and credibility
(31:51):
he had established through the Moonshot facilitated collaboration on other
health challenges. For those who had worked with Biden on
the Moonshot, his decision to relaunched the initiative as president
in twenty twenty two represented a natural extension of his
long standing commitment. The Cancer Moonshot two point zero incorporated
lessons learned from the original effort while setting even more
(32:13):
ambitious goals, including reducing cancer death rates by at least
fifty percent over twenty five years. This renewed Moonshot maintained
the original's emphasis on collaboration and coordination while incorporating new
scientific advances and addressing evolving challenges in cancer care. It
placed increased focus on early detection technologies, innovative clinical trial designs,
(32:34):
and addressing environmental factors contributing to cancer risk. President Biden's
own recent diagnosis with prostate cancer adds another profound dimension
to the Cancer Moonshot's evolution. The man who led the
nation's accelerated cancer research effort, first as a grieving father
and then as a president, has now become a cancer
patient himself. This personal experience with the disease adds yet
(32:57):
another layer to his unique perspective on cancer pola. Unlike
the aggressive brain cancer that took his son's life, Biden's
prostate cancer appears to have been caught early and is
considered highly treatable. This difference highlights the critical importance of
early detection and screening, a key focus area for both
iterations of the Cancer Moonshot. Biden has used his diagnosis
(33:19):
as an opportunity to encourage Americans, particularly men in high
risk age groups, to follow recommended screening guidelines. The President's
willingness to discuss his cancer diagnosis publicly continues his pattern
of using personal experience to advance public health. By sharing
his own medical journey, Biden helps normalize cancer as a
health condition that affects millions of Americans, rather than a
(33:41):
stigmatized disease to be hidden or feared. This openness contributes
to the Moonshot's goal of changing the culture around cancer.
In many ways, the cancer Moonshot represents the intersection of
Biden's personal journey in public service. A policy initiative born
from private grief that evolved into a national mission, it
demonstrates how effective governance can emerge from the authentic integration
(34:04):
of personal experience and political leadership, rather than their separation.
For those studying political leadership, the Moonshot offers an instructive
case study in how personal narrative can be harnessed for
public purpose without exploiting private pain. Biden's approach has never
been to center himself as a heroic figure, but rather
(34:24):
to use his experience as a bridge connecting policy discussions
to human realities. The original Cancer Moonshot also illustrates the
potential impact of focused leadership from the executive branch on
complex policy challenges. By designating the initiative as a priority
and providing sustained attention from the Vice President's office, the
Obama administration elevated cancer research coordination in ways that might
(34:48):
not have happened through normal bureaucratic channels. This high level
attention created both practical resources and symbolic momentum. Federal agencies
prioritized Moonshot related activities knowing they had support from senior leadership.
Private sector partners saw value in participating in an initiative
with Vice presidential backing, and the research community benefited from
(35:10):
the spotlight the Moonshot placed on their work. The Cancer
Moonshot's evolution across administrations also demonstrates how bipartisan health initiatives
can maintain continuity despite political transitions. While the Trump administration
did not emphasize the Moonshot as a branded initiative, much
of its work continued through the National Cancer Institute and
other federal agencies, sustained by the funding provided through the
(35:33):
twenty first Century Cures Act. This continuity reflected both the
initiative's careful institutional design and the broad political consensus supporting
cancer research. By establishing structures that could function regardless of
which party controlled the White House, Biden and his team
ensured the Moonshot would have lasting impact beyond their time
in office. When Biden relaunched the Moonshot as president in
(35:56):
twenty twenty two, he built upon this foundation while apting
to new scientific and political realities. The COVID nineteen pandemic
had demonstrated both the potential for rapid biomedical innovation when
resources and attention are mobilized and the devastating consequences of
health disparities. These lessons informed the Moonshot two point zero's
(36:16):
approach to accelerating cancer progress while ensuring equitable access to advances.
The renewed Moonshot also reflected evolving understanding of cancer biology.
Since the original initiatives launch in twenty sixteen, research had
further revealed cancer's complexity and heterogeneity, with growing recognition that
cancer encompasses hundreds of distinct diseases, requiring tailored approaches. This
(36:40):
scientific reality shaped the Moonshot two point zero's emphasis on
precision prevention and treatment strategies. Throughout both iterations of the
Cancer Moonshot, a consistent theme has been the integration of
scientific innovation with human compassion. Biden has repeatedly emphasized that
the ultimate measure of the initiative's success is not just
(37:00):
in research papers published or clinical trials completed, but in
lives extended and suffering reduced. This dual focus on scientific
progress and human impact distinguishes the Moonshot from some previous
biomedical research initiatives that emphasize basic science advances without clear
connections to patient outcomes. It reflects Biden's understanding, shaped by
(37:22):
his family's experience, that scientific breakthroughs matter most when they
translate into meaningful improvements for patients and families facing cancer.
As the Moonshot continues to evolve, its legacy extends beyond
specific research programs or policy changes. It has helped transform
how we approach cancer not as an inevitable tragedy, but
as a complex, multifaceted challenge that can be addressed through
(37:45):
coordinated effort across sectors and disciplines. This shift in perspective
may ultimately prove as valuable as any individual scientific discovery.
The initiative has also helped elevate the voices of patients
and survivors in cancer research and policy. By consistently including
patient representatives in Moonshot activities and emphasizing the importance of
(38:06):
patient reported outcomes, Biden established new norms for meaningful patient
engagement that continue to influence how cancer research is conducted.
For communities historically underrepresented in cancer research and underserved by
the healthcare system, the Moonshot's emphasis on equity opened new
possibilities for inclusion efforts to diversify clinical trial participation, address
(38:28):
environmental justice concerns, related to cancer risk and reduce outcome
disparities across demographic groups have helped ensure cancer progress benefits
all Americans. The Cancer Moonshot's journey from personal mission to
national initiative embodied Biden's approach to governance, finding common ground
on issues that matter to Americans across political and demographic divides.
(38:49):
It demonstrated that even in an era of intense polarization,
certain challenges can unite rather than divide, especially when framed
in terms of shared human experience rather than art as
an ideology. As President Biden now faces his own cancer
diagnosis while simultaneously leading national cancer policy initiatives, he embodies
both the progress made against the disease and the work
(39:12):
that remains. His unique perspective as grieving father, policy architect,
and cancer patient provides a powerful lens through which to
view the ongoing effort to reduce cancer's toll. The Cancer
Moonshot's story is ultimately about hope, not the false hope
of simple solutions or immediate cures, but the authentic hope
that comes from witnessing what coordinated human effort can accomplish.
(39:34):
It's about what becomes possible when we bring together the
best of science, policy, and human compassion in service of
reducing suffering and extending lives. This hope sustains the cancer
community through the inevitable setbacks and challenges of scientific research.
It motivates continued investment in prevention, early detection, and treatment advances,
(39:56):
and it inspires the next generation of researchers, clinicians, and
advocates to join the fight against the disease that has
touched nearly every American family. The journey from Bo Biden's
cancer diagnosis to the National Cancer Moonshot illustrates how personal
tragedy can catalyze public good, how one family's suffering can,
through committed leadership and collective action, help reduce suffering for
(40:19):
countless others. This transformation of private pain into public purpose
represents the Cancer Moonshot's most profound legacy and Joe Biden's
most personal contribution to American public health. Thanks for listening.
Please subscribe for more episodes in this series on President
Biden's cancer diagnosis and initiatives. This has been brought to
(40:40):
you by Quiet Please Podcast Networks. For more content like this,
please go to Quiet Please dot ai Quiet, Please dot
Ai hear what matters?
Popular Podcasts
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Law & Order: Criminal Justice System - Season 1 & Season 2
Season Two Out Now! Law & Order: Criminal Justice System tells the real stories behind the landmark cases that have shaped how the most dangerous and influential criminals in America are prosecuted. In its second season, the series tackles the threat of terrorism in the United States. From the rise of extremist political groups in the 60s to domestic lone wolves in the modern day, we explore how organizations like the FBI and Joint Terrorism Take Force have evolved to fight back against a multitude of terrorist threats.